Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Neuromuscul Disord. 2018 Jun 27;28(9):778–786. doi: 10.1016/j.nmd.2018.06.007

Fig. 1. Comparison of affected individuals with various disease durations.

Fig. 1

There is a declining trend in affected individuals with increased disease duration compared to more recently symptomatic individuals. However, the relationships are not strong. (a) IBMFRS score vs. Disease Duration (y = −0.4017x + 31.735, r 2 = 0.09) (b) 6MWT distance vs. Disease Duration (y = −9.7058x + 481.33, r 2 = 0.10) (c) MRC Total vs. Disease Duration (y = −1.5003x + 122.25, r 2 = 0.24).